End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain Article

Farrell, Ann T, Panepinto, Julie, Carroll, C Patrick et al. (2019). End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain . BLOOD ADVANCES, 3(23), 3982-4001. 10.1182/bloodadvances.2019000882

Open Access International Collaboration

cited authors

  • Farrell, Ann T; Panepinto, Julie; Carroll, C Patrick; Darbari, Deepika S; Desai, Ankit A; King, Allison A; Adams, Robert J; Barber, Tabitha D; Brandow, Amanda M; DeBaun, Michael R; Donahue, Manus J; Gupta, Kalpna; Hankins, Jane S; Kameka, Michelle; Kirkham, Fenella J; Luksenburg, Harvey; Miller, Shirley; Oneal, Patricia Ann; Rees, David C; Setse, Rosanna; Sheehan, Vivien A; Strouse, John; Stucky, Cheryl L; Werner, Ellen M; Wood, John C; Zempsky, William T

sustainable development goals

authors

publication date

  • December 10, 2019

webpage

published in

keywords

  • ACUTE CHEST SYNDROME
  • BACK-PAIN
  • FUNCTIONAL CONNECTIVITY
  • HEALTH-CARE
  • Hematology
  • Life Sciences & Biomedicine
  • NEUROPATHIC PAIN
  • PSYCHOMETRIC PROPERTIES
  • QUALITY-OF-LIFE
  • SELF-EFFICACY
  • SILENT CEREBRAL INFARCTS
  • Science & Technology
  • VASOOCCLUSIVE CRISIS

Digital Object Identifier (DOI)

publisher

  • ELSEVIER

start page

  • 3982

end page

  • 4001

volume

  • 3

issue

  • 23